NRX Pharmaceuticals (NRXP) Prepaid Assets (2017 - 2026)
NRX Pharmaceuticals (NRXP) posted quarterly Prepaid Assets of $467000.0 for Q1 2026, down 72.66% year-over-year from $1.7 million in Q1 2025, and up 63.29% quarter-over-quarter from $286000.0 in Q4 2025.
NRX Pharmaceuticals (NRXP) Prepaid Assets (2017 - 2026) Analysis & Trends
NRX Pharmaceuticals (NRXP) has reported Prepaid Assets for 10 consecutive years, with $467000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets fell 72.66% year-over-year to $467000.0; the TTM figure through Mar 2026 stood at $467000.0 (down 72.66% YoY), while the FY2025 annual figure was $286000.0, up 37.5% from the prior year.
- Prepaid Assets climbed to $467000.0 in Q1 2026 per NRXP's latest filing, from $286000.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $6.5 million in Q2 2022 and bottomed at $128000.0 in Q1 2024.
- Historically, Prepaid Assets has averaged $1.8 million across 5 years, with a median of $1.1 million in 2023.
- Annual changes were most pronounced in 2022 — Prepaid Assets jumped 26282.17% — and 2024, when it plunged 96.07%.
- NRX Pharmaceuticals' Prepaid Assets stood at $331000.0 in 2022, then surged by 225.68% to $1.1 million in 2023, then slumped by 80.71% to $208000.0 in 2024, then jumped by 37.5% to $286000.0 in 2025, then jumped by 63.29% to $467000.0 in 2026.
- Business Quant data shows NRXP's Prepaid Assets at $467000.0 in Q1 2026, $286000.0 in Q4 2025, and $335000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | NRX Pharmaceuticals | 132.53 Mn | 105.83 Mn | 426,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 467,000.00 |
| Dec 31, 2025 | 286,000.00 |
| Sep 30, 2025 | 335,000.00 |
| Jun 30, 2025 | 1.68 Mn |
| Mar 31, 2025 | 1.71 Mn |
| Dec 31, 2024 | 208,000.00 |
| Sep 30, 2024 | 421,000.00 |
| Jun 30, 2024 | 646,000.00 |
| Mar 31, 2024 | 128,000.00 |
| Dec 31, 2023 | 1.08 Mn |
| Sep 30, 2023 | 4.19 Mn |
| Jun 30, 2023 | 2.02 Mn |
| Mar 31, 2023 | 3.25 Mn |
| Dec 31, 2022 | 331,000.00 |
| Sep 30, 2022 | 4.85 Mn |
| Jun 30, 2022 | 6.52 Mn |
| Mar 31, 2022 | 2.07 Mn |
| Dec 31, 2021 | 5.11 Mn |
| Sep 30, 2021 | 6.35 Mn |
| Jun 30, 2021 | 51,642.00 |